VCI Wealth Management LLC Buys 9,105 Shares of Agilent Technologies, Inc. $A

Key Points

• VCI Wealth Management increased its Agilent Technologies stake by 70.5% in the second quarter, buying 9,105 additional shares and bringing its holdings to 22,020 shares valued at approximately $2.93 million.
• Agilent reported quarterly EPS of $1.49, exceeding estimates of $1.41, while revenue rose 10% year over year to $1.83 billion. The company reaffirmed FY 2026 EPS guidance of $6.00–$6.10.
• Analysts maintain a “Moderate Buy” consensus with an average price target of $160.24, compared with the stock’s recent opening price of $148.55; Agilent also pays a quarterly dividend of $0.255 per share.

VCI Wealth Management LLC raised its stake in Agilent Technologies, Inc. (NYSE:A - Free Report) by 70.5% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 22,020 shares of the medical research company's stock after buying an additional 9,105 shares during the period. VCI Wealth Management LLC's holdings in Agilent Technologies were worth $2,925,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also added to or reduced their stakes in the stock. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in shares of Agilent Technologies by 4.3% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company's stock valued at $82,712,000 after purchasing an additional 24,687 shares during the period. Mirae Asset Global Investments Co. Ltd. increased its holdings in Agilent Technologies by 20.9% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 53,422 shares of the medical research company's stock worth $7,269,000 after purchasing an additional 9,236 shares during the period. Dudley & Shanley Inc. raised its position in Agilent Technologies by 25.9% during the 2nd quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company's stock valued at $9,232,000 after purchasing an additional 14,300 shares in the last quarter. Crossmark Global Holdings Inc. raised its position in Agilent Technologies by 39.6% during the 4th quarter. Crossmark Global Holdings Inc. now owns 33,918 shares of the medical research company's stock valued at $4,615,000 after purchasing an additional 9,615 shares in the last quarter. Finally, Capricorn Fund Managers Ltd purchased a new stake in shares of Agilent Technologies in the 1st quarter worth $8,161,000.

Agilent Technologies Trading Down 0.5%

Shares of NYSE:A opened at $148.55 on Friday. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $160.27. The business's fifty day simple moving average is $135.38 and its 200-day simple moving average is $125.56. The company has a market capitalization of $41.95 billion, a PE ratio of 29.83, a P/E/G ratio of 2.63 and a beta of 1.25. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business's revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, equities research analysts predict that Agilent Technologies, Inc. will post 6.03 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were given a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, June 30th. Agilent Technologies's dividend payout ratio is presently 20.48%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on A shares. Bank of America raised Agilent Technologies from a "neutral" rating to a "buy" rating and dropped their price target for the stock from $150.00 to $145.00 in a research report on Thursday, May 28th. Piper Sandler started coverage on Agilent Technologies in a report on Thursday, June 11th. They issued a "neutral" rating and a $150.00 price objective for the company. Wells Fargo & Company lowered their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating for the company in a research note on Thursday, May 28th. Sanford C. Bernstein initiated coverage on shares of Agilent Technologies in a report on Friday, June 26th. They set an "outperform" rating and a $155.00 target price on the stock. Finally, Barclays raised their target price on shares of Agilent Technologies from $145.00 to $150.00 and gave the company an "overweight" rating in a research report on Wednesday, June 24th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, Agilent Technologies presently has a consensus rating of "Moderate Buy" and a consensus price target of $160.24.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source